发明名称 LHRH antagonists.
摘要 In this invention, a release-delaying system is to be developed for LHRH antagonists, in particular for cetrorelix, which allows the active compound to be released in a controlled manner over several weeks by complexation with suitable biophilic carriers. The acidic polyamino acids polyglutamic acid and polyaspartic acid were selected for complexation with cetrorelix. The cetrorelix polyamino acid complexes are prepared from aqueous solutions by combination of the solutions and precipitation of the complexes, which are subsequently centrifuged off and dried over P2O5 in vacuo. If complexes having a defined composition are to be obtained, lyophilization proves to be a suitable method. The cetrorelix-carboxylic acid complexes were also prepared from the aqueous solutions. In the random liberation system, the acidic polyamino acids poly-Glu and poly-Asp showed good release-delaying properties as a function of the hydrophobicity and the molecular mass of the polyamino acid. In animal experiments, it was possible to confirm the activity of the cetrorelix-polyamino acid complexes as a depot system in principle. It is thus possible by complexation of cetrorelix with polyamino acids to achieve testosterone suppression in male rats over 600 hours. The release of active compound here can be controlled by the nature and the molecular mass of the polymers.
申请公布号 ZA9802225(B) 申请公布日期 1998.04.03
申请号 ZA19980002225 申请日期 1998.03.17
申请人 ASTA MEDICA AKTIENGESELLSCHAFT 发明人 PROF. DR. JUERGEN ENGEL;DR. WOLFGANG DEGER;DR. THOMAS REISSMANN;PROF. GUENTER LOSSE;DR. WOLFGANG NAUMANN;SANDRA MURGAS
分类号 A61K47/48;A61K38/09;A61K38/24;A61K45/00;A61P35/00 主分类号 A61K47/48
代理机构 代理人
主权项
地址